Tuesday, March 2, 2021
  • Login
  • Register
Southern News Network
Advertisement
  • Home
  • Kashmir
  • Jammu
  • National
  • Health
  • Business
  • Education
  • Ladakh
  • Sports
  • World
Southern News Network
  • Home
  • Kashmir
  • Jammu
  • National
  • Health
  • Business
  • Education
  • Ladakh
  • Sports
  • World
No Result
View All Result
Plugin Install : Cart Icon need WooCommerce plugin to be installed.
Southern News Network
No Result
View All Result

Coronavirus | Oxford vaccine trial put on hold over safety concern

SNN DESK by SNN DESK
September 9, 2020
in Health
0 0
0
Home Health


AstraZeneca Plc has put a hold on the late-stage trial of its highly-anticipated COVID-19 vaccine candidate after a suspected serious adverse reaction in a study participant, health news website Stat News reported on Tuesday.

It quoted an AstraZeneca spokesperson as saying in a statement that the “standard review process triggered a pause to vaccination to allow review of safety data.

The study is testing a COVID-19 vaccine being developed by AstraZeneca and University of Oxford researchers at sites including India, the United States and the United Kingdom, where the adverse event was reported.

The nature of the safety issue and when it happened were not immediately known, although the participant is expected to recover, according to Stat News.

The report said suspension of the trial was having an impact on other AstraZeneca vaccine trials – as well as on clinical trials being conducted by other vaccine makers.

Nine leading U.S. and European vaccine developers pledged on Tuesday to uphold scientific safety and efficacy standards for their experimental vaccines despite the urgency to contain the coronavirus pandemic.

The companies, including AstraZeneca, Pfizer Inc and GlaxoSmithKline, issued what they called a “historic pledge” after a rise in concern that safety standards might slip in the face of political pressure to rush out a vaccine.

The companies said they would “uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first COVID-19 vaccines.”.

The other signatories were Johnson & Johnson, Merck & Co, Moderna Inc, Novavax Inc, Sanofi and BioNTech.

ShareTweetSendSharePinShareShare
SNN DESK

SNN DESK

Next Post
Health Ministry issues SOP guidelines for partial reopening of schools for class 9 to 12 from Sept 21

Health Ministry issues SOP guidelines for partial reopening of schools for class 9 to 12 from Sept 21

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Result
View All Result

Recent Posts

  • Lottery Scam: CBK arrests three non-locals
  • Farooq Takes First Jab Of Covid Vaccine, Omar Urges Others To Get It
  • HC lawyers asked to test for covid-19 after senior colleague tests positive
  • Transporters charge as per whims and fancies in Kashmir, top Association says it’s wrong
  • Mutton Crisis: Meeting between Govt, dealers fails to break ice

Recent Comments

    Southern News Network

    Powered By - Window Technologies

    Navigate Site

    • About Us
    • Contact Us
    • Home
    • Privacy Policy
    • Sample Page

    Follow Us

    No Result
    View All Result
    • Home
    • Kashmir
    • Jammu
    • National
    • Health
    • Business
    • Education
    • Ladakh
    • Sports
    • World

    Powered By - Window Technologies

    Welcome Back!

    Login to your account below

    Forgotten Password? Sign Up

    Create New Account!

    Fill the forms below to register

    All fields are required. Log In

    Retrieve your password

    Please enter your username or email address to reset your password.

    Log In

    Add New Playlist

    error: Content is protected !!